This site is intended for Healthcare Professionals only.

Search here...

Tag: Glenmark Pharmaceuticals Limited; Dipeptidyl Peptidase 4 inhibitor; fixed-dose combination; type 2 diabetes; Remogliflozin-Vildagliptin-Metformin

spot_imgspot_img

Glenmark launches tablet to control type 2 diabetes in India which costs just £0.16

News Pri Mandav Pri Mandav -
Glenmark Pharmaceuticals has launched a fixed-dose combination drug for the management of type 2 diabetes patients in India which costs just £0.16 per tablet. According...

Follow us

Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy

Company

Latest news

Over 700 pharmacies in Wales to offer electronic prescriptions to patients

News 0
Adopting electronic prescriptions will simplify the reimbursement process, enhance...

Medicine shortages: New report reveals “shock rise” in shortages of antibiotics, epilepsy medication

News 0
The number of notifications issued by drug companies warning...

Phlo Pharmacy secures £9 Million in funding amidst challenging investor climate

News 0
Phlo's pharmacy integrated digital healthcare ecosystem revolutionizes patient care...

Popular news

EXCLUSIVE – Andrew Lane: Empowering pharmacy contactors

BIG INTERVIEW 0
After two days of intense deliberation on the future...

NHS to address workforce shortage by recruiting 2,000 doctors from India

News 0
The shortage of doctors in the country is attributed...

LloydsPharmacy confirms exit from the high street

News 0
The chain has closed four stores and sold all...

Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc

This site is intended for Healthcare Professionals only.